Quantum BioPharma Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QNTM research report →
About the company
Quantum BioPharma Ltd. , a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.
- CEO
- Zeeshan Saeed
- IPO
- 2018
- Employees
- 17
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $15.75M
- P/E
- -0.43
- P/S
- 0.00
- P/B
- 26.39
- EV/EBITDA
- -0.40
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -621.76%
- ROIC
- 819.14%
- Revenue
- $0 · 0.00%
- Net Income
- $-26,175,286 · -84.30%
- EPS
- $-8.11 · 35.07%
- Op Income
- $-15,302,374
- FCF YoY
- -21.88%
- 52W High
- $31.91
- 52W Low
- $2.07
- 50D MA
- $5.02
- 200D MA
- $7.33
- Beta
- 0.40
- Avg Volume
- 367.38K
Get TickerSpark's AI analysis on QNTM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our QNTM coverage
Recent articles, reports, and earnings notes.
No research on QNTM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QNTM report →Similar companies
Peers in the same neighborhood.